Ajooni Biotech Intrinsic Value
Ajooni Biotech intrinsic value. Ajooni Biotech (AJOONI) median intrinsic value is ₹6.04 from 8 valuation models (range ₹1–₹9), vs current price ₹3.02 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Read AJOONI dividend history for the complete payout history and dividend yield track record.
AJOONI Valuation Methods Summary — DCF, Graham Number & P/E
Ajooni Biotech intrinsic value across 8 models vs current price ₹3.02 — upside/downside and value range per method. Compare with AJOONI fair value to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.40 | ₹1.92 - ₹2.88 | -20.5% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹7.55 | ₹6.79 - ₹8.30 | +150.0% | Book Value/Share: ₹26.76, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹6.04 | ₹5.44 - ₹6.64 | +100.0% | Revenue/Share: ₹63.82, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹6.04 | ₹5.44 - ₹6.64 | +100.0% | EBITDA: ₹9.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹7.55 | ₹6.04 - ₹9.06 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.28 | ₹1.15 - ₹1.41 | -57.6% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.72 | ₹1.55 - ₹1.89 | -43.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹9.06 | ₹8.15 - ₹9.97 | +200.0% | EPS: ₹0.20, BVPS: ₹26.76 |
AJOONI Intrinsic Value vs Market Price — All Valuation Models
Ajooni Biotech fair value range ₹1–₹9 vs current market price ₹3.02 across 8 valuation models. For current market price and key ratios, visit AJOONI share price.
AJOONI Intrinsic Value Analysis — Undervalued or Overvalued?
Ajooni Biotech median intrinsic value ₹6.04, current price ₹3.02 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of AJOONI?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Ajooni Biotech (AJOONI) is ₹6.04 (median value). With the current market price of ₹3.02, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹1.28 to ₹9.06, indicating ₹1.28 - ₹9.06.
Is AJOONI undervalued or overvalued?
Based on our multi-method analysis, Ajooni Biotech (AJOONI) appears to be trading below calculated value by approximately 100.0%.
AJOONI Financial Health — Key Ratios vs Industry Benchmarks
Ajooni Biotech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 75.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.81x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
AJOONI Cash Flow Quality — Operating & Free Cash Flow
Ajooni Biotech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-6 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-32 Cr | ₹-32 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹23 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-6 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |